About MultiPlan Corporation (MPLN) β Dividend Analysis 2026
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.
Is MPLN a good dividend investment in 2026?
MPLN offers a 8.64% forward yield with a 50% payout ratio. Strand Safety Score: 45/100 (Moderate Risk). The 5-year dividend CAGR of 0% is modest β investors should weigh current income against growth alternatives.
MPLN DRIP calculator β what's the difference?
With DRIP on a $10,000 investment over 10 years, your MPLN portfolio grows to $47.4K vs $9.1K without reinvestment. This is the compound interest effect in action.
MPLN dividend growth history & forecast
MPLN has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 8.64%.
Company generates negative FCF ($-12M) β borrowing to pay dividends
Debt Leverage0.0Γ Debt/EBITDA
30 / 30 pts
30/30
Debt/EBITDA 0.0Γ β low leverage, balance sheet is strong
Earnings Momentum-0.3B β -1.6B β -0.1B
15 / 30 pts
15/30
Net income grew in the latest year β positive but trend is unconfirmed
OVERALL ASSESSMENT
Dividend at moderate risk β monitor coverage and debt closely.
STRAND SCORE
45
/100
Strand Safety Scoreβ’ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
π MPLN Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MPLN.
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
π― MPLN Income Goal & Break-Even
Dividend Break-Even
14yr
Years for dividends to fully repay your MPLN investment of $23.15/share (πΊπΈ US Taxable (15%) Β· 15.00% tax)
$10K invested Β· 10 Years
Dividends earned (DRIP)
$38.5K
Lost to inflation (2.8% CPI)
β$2.5K
Real purchasing power gain
$36.0K
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in MPLN for:
Shares needed
14,118
Capital required
$326,832
Monthly income
$2,000
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
π MPLN Dividend Payment Schedule
MPLN pays quarterly β 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
π°
Apr
May
Jun
π°
Jul
Aug
Sep
π°
Oct
Nov
Dec
π°
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
π MPLN vs Healthcare Benchmarks
How MPLN compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yieldβ²+5.84% vs sectorBetter
MPLN
8.64%
avg
2.80%
5Y Dividend CAGRβΌ-6.80% vs sectorBelow avg
MPLN
0.00%
avg
6.80%
Payout Ratioβ²-5.00% vs sectorBetter
MPLN
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MPLN sourced from FMP /financial-growth endpoint β real data, not estimates.
ποΈ MPLN Insider Activity
β² 6 Buys
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
Insider
Title
Type
Date
Shares
Price
Total Value
Kim Michael
officer: SVP, Chief Information Officer
Buy
2024-11-15
40,000
$6.24
$249.6K
Misencik Tiffani
officer: SVP, Chief Growth Officer
A-Award
2024-10-14
95,328
β
β
O'Neil Tara
officer: SVP, General Counsel
Other
2021-03-29
18,875
$5.76
$108.7K
O'Neil Tara
officer: SVP, General Counsel
Other
2022-03-01
25,221
$3.75
$94.6K
Mintz William B.
officer: SVP, Corp. Affairs/Strategy
Buy
2024-08-07
197,000
$0.40
$78.8K
Mintz William B.
officer: SVP, Corp. Affairs/Strategy
Buy
2024-08-06
81,165
$0.31
$25.6K
Dalton Travis
director, officer: Pres., Chief Executive Officer
Buy
2024-08-07
500,000
$0.37
$185.0K
Garis Douglas Michael
officer: EVP, CFO & Treasurer
A-Award
2024-08-05
4,901,960
$0.28
$1.37M
Garis Douglas Michael
officer: EVP, CFO & Treasurer
Buy
2024-08-06
150,000
$0.31
$46.5K
Garis Douglas Michael
officer: EVP, CFO & Treasurer
Buy
2024-08-06
1,000,000
$0.30
$299.3K
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
π―
Analyst Price Target
Wall Street consensus
Current Price
$23.15
Analyst Target
$10.00
Upside / Downside
-56.8%
Range
$10.00 β $10.00
π‘ If MPLN reaches the analyst target of $10.00, investors buying today at $23.15 would see an effective yield of 20.00% on shares purchased at target price β vs 8.64% at current price.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
π¬
Financial Health Scores
Altman Z-Score
-0.41
π΄ Distress Zone β elevated dividend cut risk
Safe: >3.0 Β· Grey: 1.81β3.0 Β· Distress: <1.81
Piotroski F-Score
5/9
β οΈ Moderate fundamentals
Strong: 7β9 Β· Moderate: 4β6 Β· Weak: 0β3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
π About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MPLN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β